This review highlights the enormous development and therapeutic potential of multiple infectious viruses and viral vectors that, using very different strategies, can regulate the altered VEGF levels in multiple pathologies, with particular relevance in cancer and those associated with ocular vascularization. The gene discussed is VEGFA; the disease is cancer.